eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Endemic STDs in remote communities: the challenge for STD control

High rates of STDs in Australian Aboriginal communities point to limitations in current surveillance and control methods

MJA 1997; 166: 456


Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au/>".

Register to be notified of new articles by e-mail - Current contents list - ©MJA1997


A recent MJA editorial recognised Australia's achievements in controlling sexually transmitted disease (STD), but emphasised that the necessary aim must be "striving to eliminate endemic disease".1 Two articles in this issue of the Journal2,3 highlight the problems in the path of this objective -- and some of the potential solutions.

Our information on the extent of STD in the population is largely derived from a passive notification system. Sentinel sites that routinely screen their client population for STDs and community surveys supplement the data from notification systems. Sentinel surveillance for HIV is conducted at urban sexual health clinics and data are collated nationally by the National Centre for HIV Epidemiology and Clinical Research, but there is no national collection of sentinel data for STD outside sexual health clinics. Our understanding of the epidemiology of STD outside the cities and towns is incomplete.

What you test for is what you see, and our passive notification systems may be blind to much STD in the community Nationally, notifications of gonorrhoea and syphilis have declined in recent years,4 but celebration may be premature. The community-based survey reported in this issue by Skov et al. demonstrates that our notification systems may not provide an accurate picture of STD distribution in Australia.2 Their study found a far higher rate of gonorrhoea and chlamydia than would have been expected from previous notification data. Notifications made as a result of their community screening were responsible for a significant part of the 59% increase in notifications of gonorrhoea in South Australia in 1995.5 What you test for is what you see, and our passive notification systems may be blind to much STD in the community.

At present, notifications are more often received from communities that recognise STD as an important health issue. Thus, communities that act on their responsibility for sexual health and STD control run the risk of being denigrated because of their apparently high rates of STD, while other communities not active in sexual health may have similar or bigger problems that remain largely hidden.

The problem of detecting cases of STD is also an issue in evaluating the extent of their complications, which often form the greatest burden of disease. As shown in the report by Mein and Bowden (page 464 of this issue of the Journal),3 this burden falls heavily upon women in Aboriginal communities. What is perhaps most alarming in their case review is that only 45% of patients admitted to a gynaecological ward with suspected pelvic inflammatory disease were tested appropriately for STD (by endocervical swab). The rates of infection calculated by Mein and Bowden are therefore only the minimum estimate of gonococcal and chlamydial infection in pelvic inflammatory disease.

The effort to control STD in Aboriginal communities can be facilitated by using new technology. In particular, tests based on the polymerase chain reaction (PCR) can diagnose chlamydia and gonorrhoea from urine samples. Such samples can be collected and processed more easily than swabs, and the procedure is more acceptable to Aboriginal people.

This application of PCR technology is still in its infancy, and there may be some interpretation problems. The PCR test detects DNA or RNA, but does not tell us if the material comes from an infectious organism or from non-infectious remnants of a resolving infection. Another problem is that PCR testing does not allow the determination of antibiotic sensitivity patterns. Sentinel surveillance activities (involving culture for gonorrhoea to determine trends in antimicrobial resistance) must continue so that control efforts are not frustrated by drug resistance.

PCR technology can be used in two ways in STD control. Firstly, in community surveys, such as that described by Skov et al.2 This survey, a collaborative effort between Aboriginal and government health services, required considerable infrastructure and community consultation, which were facilitated by the TriState STD/HIV Project (funded by the Western Australian, South Australian, Northern Territory and Commonwealth health departments). The collaborative approach of the TriState STD/HIV Project offers a model for undertaking surveys of this nature.

A second application is through increased opportunistic testing by health care workers at consultations unrelated to sexual health. This approach is not necessarily easier than community surveys and represents a challenge to Aboriginal communities with limited access to health resources and a different cultural perspective on sexual matters. Opportunistic testing cannot be undertaken without prior consultation with the community and the development of guidelines on who should be tested and when. The risk of acquiring an STD is not evenly distributed within Aboriginal communities and a better understanding of social and sexual networks is needed. Mechanisms will need to be in place to inform people of test results and to ensure their treatment, and that of their contacts. The provision of adequate and acceptable community-based health services that recognise the importance of STD and have the capacity and will to detect, follow up and treat cases should be a priority. This will involve the active participation of the communities concerned and is perhaps the biggest challenge facing funders and providers of health services.

HIV is already present in Aboriginal communities but its extent is limited at present.6 Experience in Africa (where the main focus of successful prevention programs is the provision of quality STD health services, encouragement of early presentation and availability of effective treatment) suggests that our ability to control bacterial STD will be a major determinant in controlling the spread of HIV.7

The two reports published in this issue of the Journal2,3 suggest that we have a long way to go in controlling STD in remote communities. We have the technology to enable non-invasive testing for gonorrhoea and chlamydia. We now have to use it effectively to detect, treat and reduce the level of endemic disease. The challenge is there for public health professionals and involved communities.

Russell G Waddell
Clinic Manager, STD Control Branch
South Australian Health Commission

  1. Fairley CK. Sexual health -- reaching out [editorial]. MJA 1997; 166: 341-342.
  2. Skov SJ, Miller P, Hateley W, et al. Urinary diagnosis of gonorrhoea and chlamydia in men in remote Aboriginal communities. MJA 1997; 166: 468-471.
  3. Mein J, Bowden FJ. A profile of inpatient STD-related pelvic inflammatory disease in the Top End of the Northern Territory of Australia. MJA 1997; 166: 464-467.
  4. Hart G. STD epidemiology in Australasia: syphilis and gonorrhoea. Venerology 1992; 5: 115-120.
  5. South Australian Health Commission 1996. Sexually transmitted diseases in South Australia. Epidemiologic report no. 9 -- 1995. Adelaide: SAHC, 1995.
  6. Feachem RGA. Valuing the past, investing in the future: evaluation of the National HIV/AIDS strategy 1993-1994 to 1995-1996. Canberra: Department of Health, Housing and Community Services, 1995.
  7. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995: 346; 530-536.

Register to be notified of new articles by e-mail - Current contents list - To top of article - ©MJA 1997

<URL: http://www.mja.com.au/> © 1997 Medical Journal of Australia.